Global Structural Heart Devices Market 2022-2026

Global Structural Heart Devices Market 2022-2026

Technavio has been monitoring the structural heart devices market and it is poised to grow by $ 7.60 bn during 2022-2026, progressing at a CAGR of 10.03% during the forecast period. Our report on the structural heart devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of structural heart diseases, regulatory approvals of new and advanced structural heart devices, and rising awareness about structural heart diseases in developing countries. In addition, the increasing prevalence of structural heart diseases is anticipated to boost the growth of the market as well.

The structural heart devices market analysis included the method segment and geographic landscape.

Technavio's structural heart devices market is segmented as below:

By Method

• Replacement procedures
• Repair procedures

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies technological innovations in structural heart disease treatment as one of the prime reasons driving the structural heart devices market growth during the next few years. Also, the increasing number of partnerships and collaborations and the emergence of tissue-engineered heart valves will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on structural heart devices market covers the following areas:

• Structural heart devices market sizing
• Structural heart devices market forecast
• Structural heart devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading structural heart devices market vendors that include Abbott Laboratories, AFFLUENT MEDICAL SA, Artivion Inc., AtriCure Inc., Boston Scientific Corp., Braile Biomedica, CORONEO Inc., Edwards Lifesciences Corp., Getinge AB, Jc Medical Inc., Johnson and Johnson Inc., Lepu Medical Technology Beijing Co. Ltd., Lifetech Scientific Shenzhen Co. Ltd., LivaNova Plc, Medtronic Plc, Micro Interventional Devices Inc., NuMED Inc., Terumo Corp., TTK Healthcare Ltd., and W. L. Gore and Associates Inc. Also, the structural heart devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.